iSpecimen Inc
For the period ended Dec 31, 2023. Filed Mar 13, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 13, 2024
ISPC$0.74-6.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets as of December 31, 2023 and 2022
Balance Sheets
| | | | | | | |
|---|---|---|---|---|---|---|
| · · December 31, · December 31, | ||||||
| · · 2023 · · 2022 | ||||||
| ASSETS | | | | | | |
| Current assets: · · · | ||||||
| Cash and cash equivalents | | $2,343,666 | | $15,308,710 | ||
| Available-for-sale securities | | | 2,661,932 | | | — |
| Accounts receivable – unbilled | | 2,212,538 | | 2,327,789 | ||
| Accounts receivable, net of allowance for doubtful accounts of $520,897 and $230,999 at December 31, 2023 and 2022, respectively | | 728,388 | | 1,597,915 | ||
| Prepaid expenses and other current assets | | 292,079 | | 300,434 | ||
| Tax credit receivable | | — | | 140,873 | ||
| Total current assets | | 8,238,603 | | 19,675,721 | ||
| Property and equipment, net | | 127,787 | | 225,852 | ||
| Internally developed software, net | | 6,323,034 | | 4,503,787 | ||
| Other intangible assets, net | | | 908,255 | | | — |
| Operating lease right-of-use asset | | | 193,857 | | | 184,692 |
| Security deposits | | 27,601 | | 27,601 | ||
| Total assets | | $15,819,137 | | $24,617,653 | ||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | | | ||||
| Current liabilities: | | | ||||
| Accounts payable | | $3,925,438 | | $2,459,063 | ||
| Accrued expenses | | 1,540,607 | | 1,531,238 | ||
| Operating lease current obligation | | | 167,114 | | | 158,451 |
| Deferred revenue | | 415,771 | | 132,335 | ||
| Total current liabilities | | 6,048,930 | | 4,281,087 | ||
| Operating lease long-term obligation | | 29,130 | | 27,396 | ||
| Total liabilities | | 6,078,060 | | 4,308,483 | ||
| | | | | | | |
| Commitments and contingencies (See Note 9) | | | ||||
| | | | | | | |
| Stockholders’ equity | | | | | ||
| Common stock, $0.0001 par value, 200,000,000 shares authorized, 9,114,371 issued, and 9,083,371 outstanding at December 31, 2023 and 8,956,808 issued and 8,925,808 outstanding at December 31, 2022 | | 908 | | 892 | ||
| Additional paid-in capital | | 69,104,313 | | 68,573,774 | ||
| Treasury stock, 31,000 shares at December 31, 2023 and 2022, at cost | | (172) | | (172) | ||
| Accumulated other comprehensive income | | | 840 | | | — |
| Accumulated deficit | | (59,364,812) | | (48,265,324) | ||
| Total stockholders’ equity | | 9,741,077 | | 20,309,170 | ||
| Total liabilities and stockholders’ equity | | $15,819,137 | | $24,617,653 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.